- Home
- URG vs VOR Comparison
URG vs VOR Comparison
Compare URG & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | URG | VOR |
|---|---|---|
| Founded | 2004 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 699.3M | 813.3M |
| IPO Year | 2006 | 2021 |
Fundamental Metrics
Financial Performance| Metric | URG | VOR |
|---|---|---|
| Price | $1.65 | $13.11 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 10 |
| Target Price | $2.57 | ★ $45.33 |
| AVG Volume (30 Days) | ★ 10.9M | 788.9K |
| Earning Date | 05-08-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $27,207,000.00 | N/A |
| Revenue This Year | $200.42 | N/A |
| Revenue Next Year | $98.46 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.86 | $0.18 |
| 52 Week High | $2.35 | $49.95 |
Technical Indicators
Market Signals| Indicator | URG | VOR |
|---|---|---|
| Relative Strength Index (RSI) | 47.86 | 40.47 |
| Support Level | $1.65 | $11.74 |
| Resistance Level | $1.67 | $16.87 |
| Average True Range (ATR) | 0.15 | 0.90 |
| MACD | 0.02 | -0.18 |
| Stochastic Oscillator | 31.43 | 4.62 |
Price Performance
Historical ComparisonAbout URG Ur Energy Inc (Canada)
Ur-Energy Inc is engaged in uranium mining and recovery operations, with activities including the acquisition, exploration, development, and production of uranium mineral resources located in Wyoming. The company owns and operates the Lost Creek in-situ recovery uranium facility in south-central Wyoming, Lost Creek received an amendment to its license allowing the expansion of mining activities within the existing Lost Creek Project and the adjacent LC East Project; Shirley Basin; Other U.S. Projects.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.